Literature DB >> 17123873

Collaborative roles of gammaH2AX and the Rad51 paralog Xrcc3 in homologous recombinational repair.

Eiichiro Sonoda1, Guang Yu Zhao, Masaoki Kohzaki, Pawan Kumar Dhar, Koji Kikuchi, Christophe Redon, Duane R Pilch, William M Bonner, Atsushi Nakano, Masami Watanabe, Tatsuo Nakayama, Shunichi Takeda, Yasunari Takami.   

Abstract

One of the earliest events in the signal transduction cascade that initiates a DNA damage checkpoint is the phosphorylation on serine 139 of histone H2AX (gammaH2AX) at DNA double-strand breaks (DSBs). However, the role of gammaH2AX in DNA repair is poorly understood. To address this question, we generated chicken DT40 cells carrying a serine to alanine mutation at position 139 of H2AX (H2AX(-/S139A)) and examined their DNA repair capacity. H2AX(-/S139A) cells exhibited defective homologous recombinational repair (HR) as manifested by delayed Rad51 focus formation following ionizing radiation (IR) and hypersensitivity to the topoisomerase I inhibitor, camptothecin (CPT), which causes DSBs at replication blockage. Deletion of the Rad51 paralog gene, XRCC3, also delays Rad51 focus formation. To test the interaction of Xrcc3 and gammaH2AX, we disrupted XRCC3 in H2AX(-/S139A) cells. XRCC3(-/-)/H2AX(-/S139A) mutants were not viable, although this synthetic lethality was reversed by inserting a transgene that conditionally expresses wild-type H2AX. Upon repression of the wild-type H2AX transgene, XRCC3(-/-)/H2AX(-/S139A) cells failed to form Rad51 foci and exhibited markedly increased levels of chromosomal aberrations after CPT treatment. These results indicate that H2AX and XRCC3 act in separate arms of a branched pathway to facilitate Rad51 assembly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123873     DOI: 10.1016/j.dnarep.2006.10.025

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  16 in total

1.  ATR and H2AX cooperate in maintaining genome stability under replication stress.

Authors:  Rebecca A Chanoux; Bu Yin; Karen A Urtishak; Amma Asare; Craig H Bassing; Eric J Brown
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

Review 2.  Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.

Authors:  Prithviraj Bose; Yun Dai; Steven Grant
Journal:  Pharmacol Ther       Date:  2014-04-24       Impact factor: 12.310

Review 3.  Targeting abnormal DNA double strand break repair in cancer.

Authors:  Feyruz V Rassool; Alan E Tomkinson
Journal:  Cell Mol Life Sci       Date:  2010-08-10       Impact factor: 9.261

4.  Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases.

Authors:  Nan Qin; Anke Geng; Renhao Xue
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

Review 5.  Double strand break repair functions of histone H2AX.

Authors:  Ralph Scully; Anyong Xie
Journal:  Mutat Res       Date:  2013-07-31       Impact factor: 2.433

Review 6.  Balancing self-renewal against genome preservation in stem cells: How do they manage to have the cake and eat it too?

Authors:  Robert Y L Tsai
Journal:  Cell Mol Life Sci       Date:  2016-02-17       Impact factor: 9.261

7.  Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair.

Authors:  Rajesh P Rastogi; Ashok Kumar; Madhu B Tyagi; Rajeshwar P Sinha
Journal:  J Nucleic Acids       Date:  2010-12-16

8.  Increased sister chromatid cohesion and DNA damage response factor localization at an enzyme-induced DNA double-strand break in vertebrate cells.

Authors:  Helen Dodson; Ciaran G Morrison
Journal:  Nucleic Acids Res       Date:  2009-08-21       Impact factor: 16.971

9.  Co-mutation of histone H2AX S139A with Y142A rescues Y142A-induced ionising radiation sensitivity.

Authors:  James A L Brown; John K Eykelenboom; Noel F Lowndes
Journal:  FEBS Open Bio       Date:  2012-09-29       Impact factor: 2.693

10.  Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms.

Authors:  Keith W Pratz; Brian D Koh; Anand G Patel; Karen S Flatten; Weijie Poh; James G Herman; Robert Dilley; Maria I Harrell; B Douglas Smith; Judith E Karp; Elizabeth M Swisher; Michael A McDevitt; Scott H Kaufmann
Journal:  Clin Cancer Res       Date:  2016-03-15       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.